BZAD-01 is a potent, selective and orally active inhibitor of NMDA NR2B subunit, with a Ki of 72 nM. BZAD-01 can improve postural asymmetry as well as Apomorphine-induced rotation[1].
Molecular Weight:
362.27
Purity:
99.81
CAS Number:
[305339-41-7]
Formula:
C16H12F6N2O
Target:
iGluR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
